Results 241 to 250 of about 175,117 (320)
A phase IV, single‐arm, open‐label, multicenter study assessing the safety and efficacy of trastuzumab emtansine in Indian patients for the treatment of human epidermal growth factor receptor 2 (HER2)‐positive unresectable locally advanced or metastatic breast cancer who received prior treatment with trastuzumab and a taxane.
Sudeep Gupta +13 more
wiley +1 more source
Diagnosis of esophageal pleural fistula via metagenomic next-generation sequencing of pleural effusion: a case report. [PDF]
Tian J, Wang X, Zhu Y, Kong F, Sun J.
europepmc +1 more source
Awake versus intubated video-assisted thoracoscopic surgery for pleural disease: a retrospective cohort study from a single tertiary center [PDF]
Ömer Sağlam +7 more
openalex +1 more source
Summary Introduction Patients with valvular heart disease are at high risk of postoperative pulmonary complications, which contribute to morbidity and mortality. However, few studies have focused specifically on peri‐operative rehabilitation in this patient population.
Yuting Liu +16 more
wiley +1 more source
Evaluation of biomarkers sTREM-1, procalcitonin and C reactive protein in the diagnosis of pleural infection. [PDF]
Alvarenga VA +6 more
europepmc +1 more source
Background Bovine respiratory disease (BRD) is the most economically important disease affecting feedlot cattle. While viral pathogens are initiating agents, bacterial coinfections exacerbate disease severity. Vaccines for Pasteurella multocida and Histophilus somni are not commercially available in Australia.
GM Werid +5 more
wiley +1 more source
The usefulness of full-thickness biopsy during semi-rigid pleuroscopy for differentiating between malignant pleural mesothelioma and non-specific pleurisy. [PDF]
Ueda T +13 more
europepmc +1 more source
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley +1 more source

